The “Vesicular Intelligence” Strategy of Blood Cancers

Blood cancers are a heterogeneous group of disorders including leukemia, multiple myeloma, and lymphoma. They may derive from the clonal evolution of the hemopoietic stem cell compartment or from the transformation of progenitors with immune potential. Extracellular vesicles (EVs) are membrane-bound...

Full description

Bibliographic Details
Main Authors: Dorian Forte, Martina Barone, Francesca Palandri, Lucia Catani
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/12/3/416
_version_ 1797541374463049728
author Dorian Forte
Martina Barone
Francesca Palandri
Lucia Catani
author_facet Dorian Forte
Martina Barone
Francesca Palandri
Lucia Catani
author_sort Dorian Forte
collection DOAJ
description Blood cancers are a heterogeneous group of disorders including leukemia, multiple myeloma, and lymphoma. They may derive from the clonal evolution of the hemopoietic stem cell compartment or from the transformation of progenitors with immune potential. Extracellular vesicles (EVs) are membrane-bound nanovesicles which are released by cells into body fluids with a role in intercellular communication in physiology and pathology, including cancer. EV cargos are enriched in nucleic acids, proteins, and lipids, and these molecules can be delivered to target cells to influence their biological properties and modify surrounding or distant targets. In this review, we will describe the “smart strategy” on how blood cancer-derived EVs modulate tumor cell development and maintenance. Moreover, we will also depict the function of microenvironment-derived EVs in blood cancers and discuss how the interplay between tumor and microenvironment affects blood cancer cell growth and spreading, immune response, angiogenesis, thrombogenicity, and drug resistance. The potential of EVs as non-invasive biomarkers will be also discussed. Lastly, we discuss the clinical application viewpoint of EVs in blood cancers. Overall, blood cancers apply a ‘vesicular intelligence’ strategy to spread signals over their microenvironment, promoting the development and/or maintenance of the malignant clone.
first_indexed 2024-03-10T13:15:05Z
format Article
id doaj.art-0657ca40aaa441c28bd584a3635f255c
institution Directory Open Access Journal
issn 2073-4425
language English
last_indexed 2024-03-10T13:15:05Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Genes
spelling doaj.art-0657ca40aaa441c28bd584a3635f255c2023-11-21T10:24:37ZengMDPI AGGenes2073-44252021-03-0112341610.3390/genes12030416The “Vesicular Intelligence” Strategy of Blood CancersDorian Forte0Martina Barone1Francesca Palandri2Lucia Catani3IRCCS Azienda Ospedaliero—Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, Institute of Hematology “Seràgnoli”, University of Bologna, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero—Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, Institute of Hematology “Seràgnoli”, University of Bologna, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero—Institute of Hematology “Seràgnoli”, University of Bologna, 40138 Bologna, ItalyIRCCS Azienda Ospedaliero—Department of Experimental, Diagnostic and Specialty Medicine, School of Medicine, Institute of Hematology “Seràgnoli”, University of Bologna, 40138 Bologna, ItalyBlood cancers are a heterogeneous group of disorders including leukemia, multiple myeloma, and lymphoma. They may derive from the clonal evolution of the hemopoietic stem cell compartment or from the transformation of progenitors with immune potential. Extracellular vesicles (EVs) are membrane-bound nanovesicles which are released by cells into body fluids with a role in intercellular communication in physiology and pathology, including cancer. EV cargos are enriched in nucleic acids, proteins, and lipids, and these molecules can be delivered to target cells to influence their biological properties and modify surrounding or distant targets. In this review, we will describe the “smart strategy” on how blood cancer-derived EVs modulate tumor cell development and maintenance. Moreover, we will also depict the function of microenvironment-derived EVs in blood cancers and discuss how the interplay between tumor and microenvironment affects blood cancer cell growth and spreading, immune response, angiogenesis, thrombogenicity, and drug resistance. The potential of EVs as non-invasive biomarkers will be also discussed. Lastly, we discuss the clinical application viewpoint of EVs in blood cancers. Overall, blood cancers apply a ‘vesicular intelligence’ strategy to spread signals over their microenvironment, promoting the development and/or maintenance of the malignant clone.https://www.mdpi.com/2073-4425/12/3/416blood cancersextracellular vesiclesdisease biomarkerbone marrow microenvironmentangiogenesishypercoagulability
spellingShingle Dorian Forte
Martina Barone
Francesca Palandri
Lucia Catani
The “Vesicular Intelligence” Strategy of Blood Cancers
Genes
blood cancers
extracellular vesicles
disease biomarker
bone marrow microenvironment
angiogenesis
hypercoagulability
title The “Vesicular Intelligence” Strategy of Blood Cancers
title_full The “Vesicular Intelligence” Strategy of Blood Cancers
title_fullStr The “Vesicular Intelligence” Strategy of Blood Cancers
title_full_unstemmed The “Vesicular Intelligence” Strategy of Blood Cancers
title_short The “Vesicular Intelligence” Strategy of Blood Cancers
title_sort vesicular intelligence strategy of blood cancers
topic blood cancers
extracellular vesicles
disease biomarker
bone marrow microenvironment
angiogenesis
hypercoagulability
url https://www.mdpi.com/2073-4425/12/3/416
work_keys_str_mv AT dorianforte thevesicularintelligencestrategyofbloodcancers
AT martinabarone thevesicularintelligencestrategyofbloodcancers
AT francescapalandri thevesicularintelligencestrategyofbloodcancers
AT luciacatani thevesicularintelligencestrategyofbloodcancers
AT dorianforte vesicularintelligencestrategyofbloodcancers
AT martinabarone vesicularintelligencestrategyofbloodcancers
AT francescapalandri vesicularintelligencestrategyofbloodcancers
AT luciacatani vesicularintelligencestrategyofbloodcancers